Cargando…

Imaging cardiac ATTR amyloid

Detalles Bibliográficos
Autor principal:	Hawkins, Philip N
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Invited Speaker Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4642139/ http://dx.doi.org/10.1186/1750-1172-10-S1-I10

Ejemplares similares

Ophtalmologic changes in transthyretin familial amyloid polyneuropathy (ATTR-FAP)
por: Ferreira, Natália
Publicado: (2015)

Do we need to demonstrate amyloid in tissue for hereditary ATTR amyloidosis ?
por: Westermark, Per
Publicado: (2015)

Guidelines for genetic counselling in ATTR amyloidosis
por: Sequeiros, Jorge
Publicado: (2015)

Heart transplantation in hereditary ATTR amyloidosis
por: Slama, M
Publicado: (2015)

The landscape of treatment of chronic kidney disease in hereditary ATTR amyloidosis
por: Lobato, Luisa
Publicado: (2015)

Symptomatic therapy in ATTR amyloidosis: pain killers in TTR-FAP
por: Attal, Nadine
Publicado: (2015)

ATTR-FAP: liver transplantation vs oral medication, how and when
por: Erikzon, Bo Goran
Publicado: (2015)

New therapeutic perspectives – amyloid removal
por: Pepys, Mark
Publicado: (2015)

Do we need to demonstrate Amyloid in tissue?
por: Magy, Laurent
Publicado: (2015)

AL and ATTR cardiac amyloid are different: native T1 mapping and ECV detect different biology
por: Fontana , Marianna, et al.
Publicado: (2014)

Which assessment for the carriers: the cardiac view
por: Kristen, Arnt V
Publicado: (2015)

Musculoskeletal ultrasound imaging
por: Collado, Paz
Publicado: (2014)

Magnetic resonance imaging
por: Malattia, Clara
Publicado: (2014)

Imaging-guided intervention of foot and ankle disorders
por: Koulouris, George
Publicado: (2011)

Functional magnetic resonance imaging and brain functional connectivity in migraine
por: Russo, Antonio, et al.
Publicado: (2015)

Quality of life in ATTR amyloidosis
por: Lane, Thirusha, et al.
Publicado: (2015)

Lessons and challenges from RA
por: Conaghan, Philip
Publicado: (2014)

Potential inflammatory consequences in HIV controllers
por: Hunt, Peter W, et al.
Publicado: (2010)

Origin of the human malaria parasite Plasmodium falciparum in gorillas
por: Liu, Weimin, et al.
Publicado: (2010)

PReS13-SPK-1350: Autoimmune responses following vaccination in healthy populations
por: Toplak, N
Publicado: (2013)

PReS13-SPK-1212: Vaccination in paediatric patients with auto-immune and autoinflammatory diseases
por: Wulfraat, N
Publicado: (2013)

PReS13-SPK-1576: Unmeet needs in JIA treatment
por: Ruperto, N
Publicado: (2013)

Diflunisal therapy for cardiac ATTR amyloidosis: a longitudinal, prospective, single centre study
por: Quarta, Candida C, et al.
Publicado: (2015)

Novel vaccine and gene therapy approaches against HIV-AIDS
por: Das, A, et al.
Publicado: (2009)

S50. Proffered paper: Complex tumour microenvironment screening platform captures biological responses of cancer therapeutics
por: Layman, H, et al.
Publicado: (2014)

S48. Biomarker development for ipilimumab and prostate GVAX treatment
por: de Gruijl, T, et al.
Publicado: (2014)

Retroviral restriction factors: new mechanisms of innate immunity
por: Wolf, Daniel, et al.
Publicado: (2009)

ATTR Amyloidosis: development of cardiac symptoms during 6 years of follow up in different ATTR-variants
por: Klaassen, Sebastiaan, et al.
Publicado: (2015)

Native T1 mapping in ATTR cardiac amyloidosis - comparison with AL cardiac amyloidosis - a 200 patient study
por: Fontana, Marianna, et al.
Publicado: (2014)

INSP-06. Recent advances in improving neuropsychological outcomes for paediatric brain tumour patients - Are we entering a new era?
por: Mabbott, Donald
Publicado: (2022)

INSP-09. Using genetically engineered mouse models and patient-derived orthotopic xenografts to develop new therapies for pediatric brain tumors.
por: Jonchere, Barbara, et al.
Publicado: (2022)

INSP-04. Confirmatory adaptive designs for survival trials with several time-to-event endpoints
por: Schmidt, Rene
Publicado: (2022)

INSP-08. Cerebellar mutism syndrome: incidence, symptoms, risk factors, prognosis. Results and future perspectives from the Nordic-European study of the cerebellar mutism syndrome
por: Sehested, Astrid, et al.
Publicado: (2022)

INSP-03. Neuronal regulation of glioma progression
por: Monje, Michelle
Publicado: (2022)

INSP-17. Augmented Drug Delivery for Pediatric Diffuse Midline Glioma using Convection Enhanced Delivery
por: Souweidane, Mark M
Publicado: (2022)

INSP-14. Novel approaches to molecular diagnostics
por: Sahm, Felix
Publicado: (2022)

INSP-07. Improving cognitive outcomes for children treated for cancer: moving beyond the cure
por: Conklin, Heather
Publicado: (2022)

INSP-01. What to do when you cannot randomize? Leveraging Historical Data in Efficient Study Designs for Pediatric Neuro-Oncology.
por: Onar-Thomas, Arzu
Publicado: (2022)

INSP-02. WHO 2021 classification of CNS tumors
por: Wesseling, Pieter
Publicado: (2022)

INSP-16. Focused ultrasound-mediated blood-brain barrier disruption for the treatment of pediatric high-grade glioma
por: van Vuurden, Dannis, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5fmporgftmdstl9qo71dcguduc